Postsurgical treatment with pembrolizumab doubles cancer-free time for bladder cancer patients

Results from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk, muscle-invasive bladder cancer are cancer-free following surgical removal of the bladder.

FDA fast-tracks Invectys’ CAR-T therapy for renal cell carcinoma – Pharmaceutical Technology

The FDA has fast-tracked Invectys’ CAR-T therapy in renal cell carcinoma. Credit: Nemes Laszlo via Shutterstock. The US Food and Drug Administration (FDA) has granted

August 1, 2023

Sutter Health Partners with Abridge to Reduce Clinician Burnout with GenAI-Powered Documentation

What You Should Know: – Sutter Health, a leading California healthcare system, announced a major collaboration with Abridge, a company specializing in generative AI for

March 27, 2024

Red Light Holland’s Fully Owned Subsidiary, Radix Motion, Granted Patent for 3D Movement Data and AI Innovations | Psychedelic Invest

-Radix Motion granted U.S. Patent No. 11,806,162 for its movement data and AI technology -Issuing date for patent is set for November 7th, 2023 “It’s

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.